Concepedia

David S. Riddick

DS

Statistics

Publications

29

Citations

1K

H-Index

17

Active since

1989

Affiliations

University of Toronto(Current)

Queen's University

New York State Department of Health

University at Albany, State University of New York

Hospital for Sick Children

David S. Riddick is an author at University of Toronto specializing in pharmacology, cytochrome p450 enzymes, and medicine.

Publications per year

1989–2016

29

Publications

29

Ah receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation

Peter H. Jellinck, P. Gekforkert, David S. Riddick et al. · Biochemical Pharmacology · 1993 · 191 citations

Life Sciences, Biochemistry, Pharmacology +12

NADPH–Cytochrome P450 Oxidoreductase: Roles in Physiology, Pharmacology, and Toxicology

David S. Riddick, Xinxin Ding, C. Roland Wolf et al. · Drug Metabolism and Disposition · 2012 · 145 citations · Full text

Life Sciences, Pharmacology, Toxicology +16

2,3,7,8-Tetrachlorodibenzo-p-dioxin versus 3-methylcholanthrene: comparative studies of Ah receptor binding, transformation, and induction of CYP1A1.

David S. Riddick, Ying Huang, Patricia A. Harper et al. · Journal of Biological Chemistry · 1994 · 99 citations · Full text

Medicine, Molecular Biology, Pharmacology +17

CANCER CHEMOTHERAPY AND DRUG METABOLISM

David S. Riddick, Chunja Lee, Shairoz Ramji et al. · Drug Metabolism and Disposition · 2005 · 73 citations

Medicine, Oncology, Pharmacology +17

HIV protease inhibitors, saquinavir, indinavir and ritonavir: inhibition of CYP3A4-mediated metabolism of testosterone and benzoxazinorifamycin, KRM-1648, in human liver microsomes

T. Inaba, Nancy E Fischer, David S. Riddick et al. · Toxicology Letters · 1997 · 48 citations

Medicine, Pharmacokinetics, Pharmacology +16

1–5 of 29